Short answer
ORTHOPEDIATRICS CORP (KIDS) filed its Q3 2025 10-Q quarterly report on Oct 29, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $61M (up 12.2% year over year) with net income of −$12M.
Q3 2025 key financials · XBRL
- Revenue
- $61M
- +12.2% YoY · +0.3% QoQ
- Net income
- −$12M
- −48.7% YoY · −65.5% QoQ
- Operating margin
- -15.4%
- Gross margin
- 73.9%
- EPS (diluted)
- −$0.50
- −47.1% YoY · −66.7% QoQ
Source: XBRL data from the ORTHOPEDIATRICS CORP (KIDS) Q3 2025 10-Q on SEC EDGAR. USD.
ORTHOPEDIATRICS CORP Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Cash position, operating cash flow, and capital deployment details unavailable
Risk Factors
- Newly added tariff risk triggered by 2025 U.S. trade-policy changes, including 10% baseline and country-specific tariffs
- Most material update: 50% Brazil tariff effective August 6, 2025 and 15% EU tariff effective August 7, 2025
- Regulatory risk: Medicaid coverage or reimbursement reductions threatening pediatric procedure volumes and product adoption
- Near-term market risk: Tariffs and retaliation potentially increasing product costs and reducing demand
- Financial risk: International currency fluctuations potentially adversely affecting operations and cash flows
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ORTHOPEDIATRICS CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.